#Market News  14 PM / Updated 8 minutes ago BRIEF-Sanuwave Receives FDA De Novo Decision To Immediately Market Dermapace System For Treatment Of Diabetic Foot Ulcers In U.S. Reuters Staff 1 Min Read 
Jan 2 (Reuters) - Sanuwave Health Inc: 
* SANUWAVE RECEIVES FDA DE NOVO DECISION TO IMMEDIATELY MARKET THE DERMAPACE SYSTEM FOR THE TREATMENT OF DIABETIC FOOT ULCERS IN THE U.S. Source text for Eikon: Further company coverage: